Literature DB >> 4217243

Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.

W J Mroczek, S Fotiu, M E Davidov, F A Finnerty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4217243

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  6 in total

Review 1.  Responders and non-responders to antihypertensive treatment.

Authors:  C J Bulpitt
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 2.  Racial differences in antihypertensive therapy: evidence and implications.

Authors:  M H Weinberger
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

3.  Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients.

Authors:  P Seideman; A Grahnén; K Haglund; B Lindström; C Von Bahr
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

4.  Tailoring antihypertensive drug therapy for the black patient.

Authors:  J Arradondo
Journal:  J Natl Med Assoc       Date:  1987-02       Impact factor: 1.798

Review 5.  Methyldopa for primary hypertension.

Authors:  Greg T Mah; Aaron M Tejani; Vijaya M Musini
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

6.  Comparative studies of guanfacine and methyldopa.

Authors:  A Roeckel; A Heidland
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.